Deltarasin is a potent small molecule inhibitor that disrupts the KRAS-PDEdelta interaction by binding to PDEdelta with a high affinity (Kd = 38 nM). It is a valuable research tool for studying KRAS-driven cancers in both cellular and animal models, aiding in the exploration of oncogenic signaling and potential therapeutic strategies.